By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SAGE Therapeutics 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
SAGE Therapeutics (SAGE) And Collaborators Publish New Pre-Clinical Data In Neuropharmacology Demonstrating A Novel Metabotropic Mechanism Of Sage 10/20/2016 1:04:55 PM
SAGE Therapeutics (SAGE) Reports Additional Positive Data On Secondary Endpoints From Phase 2 Clinical Trial Of SAGE-547 In Severe Postpartum Depression At The MarcĂ© Society For Perinatal Mental Health Biennial Scientific Meeting 9/27/2016 11:04:46 AM
SAGE Therapeutics (SAGE) To Present At The Neurocritical Care Society 14th Annual Meeting 9/16/2016 11:01:01 AM
SAGE Therapeutics (SAGE) Announces Pricing Of Public Offering Of Common Stock 9/9/2016 10:55:26 AM
SAGE Therapeutics (SAGE) Announces Proposed Public Offering Of Common Stock 9/8/2016 10:57:48 AM
SAGE Therapeutics (SAGE) Receives FDA Breakthrough Therapy Designation For SAGE-547 For The Treatment Of Postpartum Depression 9/6/2016 11:33:54 AM
SAGE Therapeutics (SAGE) And Collaborators Announce Publication Highlighting Epidemiology And Burden Of Illness For Super-Refractory Status Epilepticus In Journal Of Medical Economics 8/30/2016 11:30:33 AM
SAGE Therapeutics (SAGE) Announces Second Quarter 2016 Financial Results and Provides Corporate Update 8/9/2016 11:02:15 AM
SAGE Therapeutics (SAGE) To Present At The Canaccord Genuity 36th Annual Growth Conference 8/4/2016 12:07:15 PM
SAGE Therapeutics (SAGE) To Report Second Quarter 2016 Financial Results On Tuesday, August 9, 2016 8/3/2016 10:44:44 AM